University of South Alabama
  University of South Alabama
Care Centers
USA Hospitals
Centers of Excellence
Clinical Research
New Doctors
News Releases
Special Events
Healthcare Professionals
Find a Doctor
USA Home | College of Medicine | Career Opportunities | Maps | FAQ | SecureLog In
USA Health System
News Release
Mobile, Ala. (June 4, 2008)
Contact: Paul Taylor, (251) 470-1682

Medical Pioneer In Use Of Taxol Treatments For Cancer Joins USA Mitchell Cancer Institute

Dr. Eddie Reed
Dr. Eddie Reed talks with local media during a recent press conference in the lobby of the USA Mitchell Cancer Institute - which is nearing completion. Over his shoulder is a glass wall termed the "wall of hope". This feature will provide visitors a clear view of the research labs where scientists will work to improve cancer treatments.

Dr. Eddie Reed has been named Professor of Oncologic Sciences and Abraham Mitchell Distinguished Investigator at the University of South Alabama (USA) Mitchell Cancer Institute. Reed, who will direct both cancer research and novel cancer therapies in Mobile, is internationally renowned for his pioneering work in the clinical development of taxol for the treatment of ovarian cancer.


Prior to his appointment at USA, Reed worked at the Centers for Disease Control (CDC) in Atlanta, where he served as director of the Division of Cancer Prevention and Control. As the senior executive administrator for cancer programs at CDC, Reed helped establish the national agenda for cancer prevention through screening, early detection and diagnosis.

“Dr. Reed is a wonderful person, an outstanding scientist, and a superb physician. He is passionately committed to improving cancer healthcare through research. We are extremely fortunate that he has chosen to join our team here in Mobile,” said Dr. Michael Boyd, director of the USA Mitchell Cancer Institute.


At the Mitchell Cancer Institute, Reed will split his efforts between his clinical practice and his research endeavors. His research will concentrate upon molecular pharmacology and clinical development of novel platinum compounds and his clinical focus will be on ovarian cancer and metastatic prostate cancer.


“I was attracted by the tremendous growth potential of the USA Mitchell Cancer Institute and Mobile, Alabama,” said Reed. “Cancer care is at its very best when you deliver cancer patients the latest in treatment options that are based on solid research. By combining state-of-the-art cancer care with state-of-the-art research, patient outcome is best.”

Reed earned his medical degree from Yale University, then completed his internship and residency at Stanford University, followed by a medical oncology fellowship at the National Cancer Institute (NCI) in Bethesda, Maryland.
From 1985 to 2001, he served in a variety of increasingly responsible roles at NCI, encompassing basic/translational and clinical research, oncology program administration, and clinical care focused upon gynecologic malignancies and metastatic prostate cancer.
In 1987, Reed was appointment senior investigator at NCI. Additionally, he served as chief of the NCI’s Medical Ovarian Cancer Section, and chief of the Clinical Pharmacology Branch, Division of Cancer Treatment. At NCI, Reed achieved international recognition for his pioneering studies on clinical development of taxol for the treatment of ovarian cancer.
In 2001, Reed moved to the University of West Virginia (UWVA) where he was appointed director of the Mary Babb Randolf Cancer Center. There he also held a tenured, endowed chair and professorship, with joint appointments in the departments of medicine, cell biology, and pharmaceutical sciences. During his time at UWVA, Reed made major administrative contributions to the development of the Cancer Center, while at the same time maintaining momentum of his research in developmental therapeutics and clinical practice in women’s cancers.
During his career, Reed has also achieved national prominence for his efforts addressing cancer health disparities and cancer control. In 2005, he was recruited to the CDC in Atlanta.
Reed is author or coauthor of more than 275 peer-reviewed research and clinical publications, and is named inventor on 8 patents. He has held major leadership roles on numerous professional committees, review panels and advisory boards at the national level for many years. He has received many prestigious awards, honors and other recognition for his leadership and accomplishments in cancer research, prevention, and treatment. He has been a frequent and widely sought after speaker at major professional conferences and symposia and other cancer-related events throughout the country and abroad. Reed was recently elected to the Board of Directors of the American Association of Cancer Research, the largest professional organization of cancer researchers and physicians worldwide.
USA Health System Physician Directory
Search for a practicing physician in the University of South Alabama, by name, by location or by specialty.
University of South Alabama - Mobile Alabama 36688-0002 / 1 (251) 460-6101
For questions or comments Contact Us
Date last changed: June 4, 2008 4:07 PM